{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:33:58Z","timestamp":1793126038763,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejps.2026.107632","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:44:29Z","timestamp":1785944669000},"page":"107632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Revisiting the literature on gastric CBD-to-THC conversion: contextualizing conflicting evidence"],"prefix":"10.1016","volume":"227","author":[{"given":"Jens B.","family":"Simonsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi Ziegler","family":"Bruun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hoeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne Skov","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107632_bib0001","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1208\/s12248-016-9952-8","article-title":"A quantitative review and meta-models of the variability and factors affecting oral drug absorption-part I: gastrointestinal pH","volume":"18","author":"Abuhelwa","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2026.107632_bib0002","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1021\/ja01866a040","article-title":"Structure of cannabidiol. VI. Isomerization of cannabidiol to tetrahydrocannabinol, a physiologically active product. Conversion of cannabidiol to cannabinol","volume":"62","author":"Adams","year":"1940","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2026.107632_bib0003","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0021-9797(83)90330-2","article-title":"Size of sodium dodecyl sulfate micelles in the presence of additives i. alcohols and other polar compounds","volume":"91","author":"Almgren","year":"1983","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejps.2026.107632_bib0004","unstructured":"B.S. (Marijuana and Hemp), Cannabidiol (CBD) market size, share & industry analysis - last updated: May 11, 2026, n.d. https:\/\/www.fortunebusinessinsights.com\/segmentation\/cannabidiol-cbd-market-103215 (accessed 24 July 2026)."},{"key":"10.1016\/j.ejps.2026.107632_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.forc.2023.100467","article-title":"The scientific controversy on the conversion of CBD into THC in the human stomach: molecular modelling and experimental results compared","volume":"32","author":"Buijs","year":"2023","journal-title":"Forensic Chem."},{"key":"10.1016\/j.ejps.2026.107632_bib0006","unstructured":"Center for Drug Evaluation and Research, Clinical pharmacology and biopharmaceutics review(S) - NDA application for Epidiolex, FDA, 2018. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2018\/210365Orig1s000ClinPharmR.pdf (accessed 24 July 2026)."},{"key":"10.1016\/j.ejps.2026.107632_bib0007","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1089\/can.2022.0235","article-title":"Re-examining cannabidiol: conversion to tetrahydrocannabinol using only heat","volume":"9","author":"Daniels","year":"2024","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.ejps.2026.107632_bib0008","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the Lennox\u2013Gastaut syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2026.107632_bib0009","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/npp.2017.204","article-title":"The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain","volume":"43","author":"Donvito","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejps.2026.107632_bib0010","first-page":"756","article-title":"Upper gastrointestinal (GI) pH in young, healthy men and women","volume":"7","author":"Dressman","year":"1990","journal-title":"Pharm. Res. An Off. J. Am. Assoc. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107632_bib0011","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/2049463717710042","article-title":"Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies","volume":"11","author":"Fallon","year":"2017","journal-title":"Br. J. Pain."},{"key":"10.1016\/j.ejps.2026.107632_bib0012","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00414-022-02896-w","article-title":"Will tetrahydrocannabinol be formed from cannabidiol in gastric fluid? An in vivo experiment","volume":"137","author":"Franz","year":"2023","journal-title":"Int. J. Legal Med."},{"key":"10.1016\/j.ejps.2026.107632_bib0013","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0040-4020(01)99446-3","article-title":"Hashish-VII: the isomerization of cannabidiol to tetrahydrocannabinols","volume":"22","author":"Gaoni","year":"1966","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejps.2026.107632_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/toxics8020041","article-title":"Conversion of cannabidiol (CBD) into psychotropic cannabinoids including tetrahydrocannabinol (THC): a controversy in the scientific literature","volume":"8","author":"Golombek","year":"2020","journal-title":"Toxics"},{"key":"10.1016\/j.ejps.2026.107632_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27186070","article-title":"Promising nanocarriers to enhance solubility and bioavailability of cannabidiol for a plethora of therapeutic opportunities","volume":"27","author":"Grifoni","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejps.2026.107632_bib0016","first-page":"102","article-title":"Even high doses of oral cannabidiol do not cause THC-like effects in humans: comment on Merrick et al","volume":"1","author":"Grotenhermen","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.ejps.2026.107632_bib0017","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/jat\/bkad043","article-title":"Conversion of water-soluble CBD to \u22069-THC in synthetic gastric fluid-an unlikely cause of positive drug tests","volume":"47","author":"Hart","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.ejps.2026.107632_bib0018","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0091-3057(91)90358-9","article-title":"Comparative metabolism of cannabidiol in dog, rat and man","volume":"40","author":"Harvey","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejps.2026.107632_bib0019","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0378-4347(91)80587-3","article-title":"Urinary metabolites of cannabidiol in dog, rat and man and their identification by gas chromatography-mass spectrometry","volume":"562","author":"Harvey","year":"1991","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.ejps.2026.107632_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/ph19020231","article-title":"Results of an exploratory crossover pharmacokinetic study evaluating a natural hemp extract-based cosmetic product: comparison of topical and oral routes of administration \u2020","volume":"19","author":"Jain","year":"2026","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejps.2026.107632_bib0021","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40005-023-00656-5","article-title":"Recent approaches to investigate drug delivery systems through the lymphatic pathway using oral lipid-based formulations","volume":"54","author":"Jeong","year":"2024","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.ejps.2026.107632_bib0022","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.12688\/f1000research.19931.7","article-title":"Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?","volume":"8","author":"Lachenmeier","year":"2024","journal-title":"F1000Res"},{"key":"10.1016\/j.ejps.2026.107632_bib0023","unstructured":"S. Machnes, Ziv; van Haarst, A.; Paglialunga, Back to basics: pH-dependent drug interactions with acid reducing agents, white pap. Ser. Drug-drug interact. Study spec. \u2013 Part 3. Celerion. (2022). https:\/\/www.celerion.com\/wp-content\/uploads\/2022\/01\/pH-Dependent-Drug-Interactions-with-Acid-Reducing-Agents_Final.pdf (accessed 24 July 2026)."},{"key":"10.1016\/j.ejps.2026.107632_bib0024","article-title":"Conversion of cannabidiol following oral administration: authors\u2019 response to Grotenhermen et al","volume":"2","author":"Bonn-Miller","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.ejps.2026.107632_bib0025","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.2174\/138161212802884780","article-title":"Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers","volume":"18","author":"Martin-Santos","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejps.2026.107632_bib0026","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1211\/jpp.60.1.0008","article-title":"Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in-vivo experiments","volume":"60","author":"McConnell","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107632_bib0027","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1089\/can.2015.0004","article-title":"Identification of psychoactive degradants of cannabidiol in simulated gastric and physiological fluid","volume":"1","author":"Merrick","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.ejps.2026.107632_bib0028","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1111\/bcp.14038","article-title":"A systematic review of cannabidiol dosing in clinical populations","volume":"85","author":"Millar","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107632_bib0029","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3389\/fphar.2018.01365","article-title":"A systematic review on the pharmacokinetics of cannabidiol in humans","volume":"9","author":"Millar","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107632_bib0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0021-9797(74)90030-7","article-title":"The critical micelle concentration of sodium dodecyl sulfate-bivalent metal dodecyl sulfate mixtures in aqueous solutions","volume":"46","author":"Moroi","year":"1974","journal-title":"J. Colloid. Interface Sci."},{"key":"10.1016\/j.ejps.2026.107632_bib0031","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1021\/mp100149j","article-title":"Physiological parameters for oral delivery and in vitro testing","volume":"7","author":"Mudie","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2026.107632_bib0032","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26062647","article-title":"Optimising cannabidiol delivery: improving water solubility and permeability through phospholipid complexation","volume":"26","author":"Muta","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2026.107632_bib0033","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/can.2017.0009","article-title":"A conversion of oral cannabidiol to Delta9-tetrahydrocannabinol seems not to occur in humans","volume":"2","author":"Nahler","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.ejps.2026.107632_bib0034","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/can.2025.0015","article-title":"Acid-catalyzed conversion of cannabidiol to tetrahydrocannabinols: en route to demystifying manufacturing processes and controlling the reaction outcomes","volume":"10","author":"Nivorozhkin","year":"2025","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.ejps.2026.107632_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/ph17020244","article-title":"Strategies to improve cannabidiol bioavailability and drug delivery","volume":"17","author":"O\u2019Sullivan","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejps.2026.107632_bib0036","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s42238-023-00186-9","article-title":"The therapeutic potential of purified cannabidiol","volume":"5","author":"O\u2019Sullivan","year":"2023","journal-title":"J. Cannabis Res."},{"key":"10.1016\/j.ejps.2026.107632_bib0037","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s40263-020-00741-5","article-title":"Critical aspects affecting cannabidiol oral bioavailability and metabolic elimination, and related clinical implications","volume":"34","author":"Perucca","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejps.2026.107632_bib0038","series-title":"The European Directorate For the Quality of Medicines & Healthcare","article-title":"Gastric juice, artificial (1039900): European Pharmacopoeia","year":"2019"},{"key":"10.1016\/j.ejps.2026.107632_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2025.114879","article-title":"Oral formulations for cannabidiol: improved absolute oral bioavailability of biodegradable cannabidiol self-emulsifying drug delivery systems","volume":"255","author":"Sandmeier","year":"2025","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.ejps.2026.107632_bib0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.14712\/23362936.2019.5","article-title":"Gastric pH in rats: key determinant for preclinical evaluation of pH-dependent oral drug absorption","volume":"120","author":"\u0160\u00edma","year":"2019","journal-title":"Prague Med. Rep."},{"key":"10.1016\/j.ejps.2026.107632_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113879","article-title":"A perspective on the apparent pKa of ionizable lipids in mRNA-LNPs","volume":"384","author":"Simonsen","year":"2025","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2026.107632_bib0042","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s42238-025-00274-y","article-title":"Beyond the hype: a comprehensive exploration of CBD\u2019s biological impacts and mechanisms of action","volume":"7","author":"Swenson","year":"2025","journal-title":"J. Cannabis Res."},{"key":"10.1016\/j.ejps.2026.107632_bib0043","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2026.107632_bib0044","unstructured":"U.S. Pharmacopeia, The dissolution procedure: development and validation. Chapter 1092, (2020). 10.31003\/USPNF_M643_05_01."},{"key":"10.1016\/j.ejps.2026.107632_bib0046","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s11095-006-9209-9","article-title":"Estimation of intragastric solubility of drugs: in what medium?","volume":"24","author":"Vertzoni","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2026.107632_bib0047","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1007\/s11095-023-03597-8","article-title":"Physiological dynamics in the upper gastrointestinal tract and the development of gastrointestinal absorption models for the immediate-release oral dosage forms in healthy adult human","volume":"40","author":"Wang","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2026.107632_bib0048","first-page":"16","article-title":"Conversion of cannabidiol to \u03949-tetrahydrocannabinol and related cannabinoids in artificial gastric juice, and their pharmacological effects in mice","volume":"25","author":"Watanabe","year":"2007","journal-title":"For. Toxicol."},{"key":"10.1016\/j.ejps.2026.107632_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2019.112170","article-title":"Study of surface properties of aqueous solutions of sodium dodecyl sulfate in the presence of hydrochloric acid and heavy metal ions","volume":"299","author":"Wo\u0142owicz","year":"2020","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejps.2026.107632_bib0050","doi-asserted-by":"crossref","DOI":"10.1089\/can.2017.0032","article-title":"Cannabidiol does not convert to \u03949-tetrahydrocannabinol in an in vivo animal model","author":"Wray","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.ejps.2026.107632_bib0045","unstructured":"U.S. Pharmacopeia, 2026 Test solutions - gastric fluid, simulated, (n.d.). http:\/\/ftp.uspbpep.com\/v29240\/usp29nf24s0_ris1s126.html (accessed 12 August 2026)."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872600206X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872600206X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:54:41Z","timestamp":1793123681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092809872600206X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":50,"alternative-id":["S092809872600206X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107632","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting the literature on gastric CBD-to-THC conversion: contextualizing conflicting evidence","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107632","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107632"}}